PPARG and fatty liver disease: Paradoxically, exacerbation of systemic insulin resistance, adiposity, and hyperlipidemia against reduced hepatic steatosis in diabetic PpargΔHEP mice corroborated that liver PPARγ protects other tissues from TAG accumulation and insulin resistance [89].